Short Bowel Syndrome Market - Teduglutide Therapy Transforming SBS...

adicionou um novo artigo Health

2026-07-17 07:50:40 -

Short Bowel Syndrome Market - Teduglutide Therapy Transforming SBS Management

Market Overview The short bowel syndrome market is transforming as teduglutide therapy reduces parenteral nutrition requirements through GLP-2 receptor agonism. The Short Bowel Syndrome Market is projected to grow through 2035, driven by enteral autonomy goals, quality of life improvement, and clinical evidence supporting widespread teduglutide adoption across gastroenterology and nutrition...

0 Comentários 0 Compartilhamentos 160 Visualizações 0 Anterior